Invivotek offers custom and standard pre-clinical services for drug discovery and development programs. They provide animal models and bioassays for in vivo testing of compounds related to immunology, inflammation, oncology, metabolic, and cardiovascular diseases. With expertise in in vivo pharmacology and phenotypic characterization of genetically modified rodents, Invivotek is a leading provider of preclinical in vivo services. Their state-of-the-art facility, along with their collective experience across multiple therapeutic areas, positions them as a trusted partner for drug discovery and early optimization.